Alkermes Insider Buy Signals Strong Confidence Ahead of FDA MilestonesAlkermes insider buys 5,000 shares amid FDA‑boosted alixorexton; learn how this 10‑year plan trade signals future upside for CNS drug developers.Alkermes PLC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 08/01/2026, 23:38 3 minutes to read
